ARCHIVES

In Brief: Hammond Resigned As ACS Officer; Wykoff Slated To Direct FDA Special Populations Office

This article is from The Cancer Letter archive.

Vol. 18 No. 45 | November 20, 1992

Download PDF Visit The Full Archive

Related Articles

New Protocol Could Improve Survival Of Rare Brain Tumor

October 30, 2009

Drug Approved in Europe For Pediatric Cancer Patients

April 24, 2009

CMS Abandons Proposal To Require Further Certification Of Clinical Trials For Coverage.

October 19, 2007

In Brief: CTEP Files IND For Antineoplaston, Mayo, MSK, Plan Trials; Researcher Escapes Bosnia

August 6, 1993

In Brief: Schmidt Advises Upton To Consider Moving Control Projects In Other Division To DCCR

December 2, 1977

Cooperative Groups Fight Back: Members Seek Move To Multidisciplinary Approach, More Funds

May 30, 1975